TMCnet News
EVERFI from Blackbaud's Prescription Drug Safety Course Certified as Meeting Rigorous ESSA Evidence StandardsRecognition validates that the course has a positive impact on students' knowledge of safe prescription drug use and potential future actions CHARLESTON, S.C., May 7, 2024 /PRNewswire/ -- EVERFI® from Blackbaud®, the leader in powering social impact through education, today announced that its program, Prescription Drug Safety: Know the truth, has been certified as meeting the evidence-based standards outlined in the Every Student Succeeds Act (ESSA), aligning with Level III certification for "Promising Evidence." This certification demonstrates that usage of the course correlates with students' personal responsibility, perceived social norms, knowledge of safe prescription drug use, and potential future actions. The ESSA certification was awarded through LearnPlatform by Instructure, following an extensive review of the research study, "Promoting Prescription Drug Safety Skills in School: Evaluating the Effectiveness of a Technology-Based Curriculum." The research study, conducted by Lynch Research Associates, found that compared to a control group of students, students who took EVERFI's prescription drug safety course saw:
Prescription drug misuse among youth aged 12-18 remains high in the United States with The National Institute on Drug Abuse indicating that approximately 2,000 teens abuse prescription drugs every single day and upwards of 3 million youth aged 12-17 admitted to abusing prescription drugs at least once in their lifetime. Public health experts and medical providers have been increasingly calling for effective, evidence-based prescription drug misuse prevention and intervention programming that reaches large numbers of youth who may be exposed to opportunities to engage in non-medical prescription drug use. "The statistics around prescription drug misuse and abuse are startling and we cannot deny that as a country, we have reached a point of crisis and urgent action is needed," said Alice Lee Schools and school districts are increasingly encouraged to use programs and tools that have been proven, through rigorously designed research studies, to positively impact student outcomes. The ESSA Levels of Evidence provide an easy-to-interpret framework for identifying what programs work. With LearnPlatform, EVERFI has a respected third-party evidence partner that solidifies the company's commitment to demonstrating the impact of its programs for students. EVERFI is committed to continuing to strengthen its library of evidence and bring high-quality evidence-based programs to educators in every classroom. Prescription Drug Safety: Know the truth is a free digital course that guides teachers and educates youth about the dangers associated with misusing prescription medications. Through real-world scenarios, students can recognize the impact prescription drug misuse can have on their physical and mental health, relationships, and future. They also learn how to support others in situations involving prescription drug misuse and overdose. Since its launch in 2017, nearly 1.3 million students have actively engaged with the curriculum, and more than 7,000 schools have used the course. For more information or to sign up for the Prescription Drug Safety: Know the truth course, visit https://everfi.com/courses/k-12/prescription-drug-safety-high-school/. About EVERFI from Blackbaud Media Inquiries Blackbaud Forward-looking Statements View original content to download multimedia:https://www.prnewswire.com/news-releases/everfi-from-blackbauds-prescription-drug-safety-course-certified-as-meeting-rigorous-essa-evidence-standards-302136537.html SOURCE EVERFI |